image of a notepad with notes (for a private tutor)

Published

November 18, 2026

·

4 min read

The Missing Context in Pharmacy Claims Data

Written by

Tony Granda

Pharmacy claims data can tell us a lot.

We can identify expensive medications, analyze utilization patterns, track prescription activity, and uncover opportunities to reduce pharmacy spend. With today's technology, we can do all of that faster and more efficiently than ever before.

But there's something claims data can't always tell us: why a patient is taking a particular medication, and whether changing anything about their treatment or how they access it is appropriate. As a pharmacist, I believe understanding that distinction is one of the most important parts of effective pharmacy cost containment.

Two Similar Claims, Two Very Different Patients

Imagine two members taking the same specialty medication at the same dosage, with nearly identical costs to their respective health plans. From a financial perspective, the claims look almost interchangeable. Both might be flagged as opportunities for lower-cost alternatives.

But clinically, those patients could have very different circumstances.

One may have responded well to the medication after trying several other treatments unsuccessfully. The other may be newly diagnosed and just beginning therapy. One may have complex medical considerations that influence treatment decisions. The other may have fewer complications.

The claims data alone won't necessarily reveal those differences and those differences matter when evaluating whether a particular intervention makes sense.

Data Identifies Opportunities. Clinical Expertise Provides Context.

I don't see technology and clinical expertise as competing approaches. They're complementary. Claims analytics can process thousands of prescriptions, recognize spending patterns, and identify medications that warrant closer examination. That's incredibly valuable, especially for employers managing growing specialty pharmacy costs.

But a potentially expensive claim isn't automatically an opportunity to change therapy. That's where pharmacist-led clinical review becomes important. A pharmacist can evaluate medication-specific considerations, review available clinical information, identify potential safety concerns, and determine whether additional information is needed before making a recommendation.

Prior authorization processes can also provide an opportunity to evaluate whether a prescribed therapy meets established clinical criteria, including whether relevant treatment history or other documentation supports its use. These aren't simply administrative steps. When designed and applied appropriately, they're important safeguards that help support responsible medication management.

The Lowest Cost Isn't Always the Right Answer

There's a temptation in pharmacy cost containment to view every expensive medication as a problem that needs to be solved, but the medication itself isn't necessarily the problem. For some patients, a high-cost therapy may be the most appropriate treatment available. The goal shouldn't be to change that treatment simply because the price is uncomfortable.

Instead, we should be asking better questions.

Can the prescribed medication be obtained through a more cost-effective, appropriate pathway? Are there clinically suitable alternatives worth discussing with the prescriber? Are there safety, formulation, or continuity considerations that need attention? And importantly, what information do we still need before making a responsible decision?

Clinical expertise helps answer those questions without reducing a patient's treatment to a line item on a spreadsheet.

Better Information Leads to Better Decisions

In my role as Director of Clinical Programs at Rescrybe, I see the value of combining analytical capabilities with pharmacist-led clinical processes. Technology helps us identify where opportunities may exist. Clinical review helps us understand which opportunities are appropriate to pursue and what additional considerations need to be addressed.

That distinction is essential because successful pharmacy cost containment is about helping employers manage costs responsibly while respecting the clinical decisions and individual circumstances behind every prescription.

The future of pharmacy cost containment will undoubtedly involve more sophisticated technology and better data. That's progress. As we more efficiently identify opportunities, the more important it becomes to understand the people behind them.

A pharmacy claim tells us what a medication costs. It doesn't tell us everything we need to know about the patient who depends on it.

‍